Survey of 82 clinics highlights technology uptake, training gaps and emerging best practice in a rapidly evolving sector.
As longevity medicine edges closer to the mainstream, a new global survey of clinics offers a comprehensive snapshot of how the sector is developing – revealing both the promise and the challenges of this emergent field. The Longevity Clinics Survey 2025, published today by Longevity.Technology and sponsored by Everest Health, draws on responses from 82 clinics across multiple continents, ranging from solo practices to larger, integrated centers. It documents not only what is being done, but how, by whom and with what tools.
Longevity.Technology: The report highlights a sector in flux; medical professionals are embracing advanced diagnostics, digital platforms and aging biomarker tests, yet standards of practice vary widely, and formal training in longevity medicine remains inconsistent. To address these challenges, initiatives such as the Roundtable of Longevity Clinics and the Biomarkers of Aging Consortium have been established. The Roundtable, organized by the International Institute of Longevity and supported by the Buck Institute for Research on Aging, serves as a collaborative platform where leading experts convene to set new benchmarks for longevity interventions and discuss pressing matters facing longevity-focused clinics. Similarly, the Biomarkers of Aging Conference, hosted by the Biomarkers of Aging Consortium, aims to provide a holistic view of the biomarkers research landscape, bridging critical gaps and driving forward meaningful advancements in the field. These initiatives speak to a collective effort within the longevity community to standardize practices, enhance training and foster innovation.
“Understanding the landscape of current longevity clinics is important to guiding the direction of a fruitful future,” writes Danielle Ruiz, CEO and Chief Medical Officer of Everest Health, in the report’s foreword. She continues: “As the field advances, qualified training and ongoing education are critical for providers to stay informed about emerging therapies, safety protocols, and scientific evidence for best practice.”
The data confirms this need: although 73% of clinics said they pursue Continuing Medical Education (CME) in healthy longevity, many respondents acknowledged the lack of formalized education pathways and recognized the need for internationally accredited training. One respondent noted: “There needs to be formalized training that’s internationally recognized. Already people with ‘interest’ are putting out expensive courses and touting unrealistic claims.”
This sentiment is echoed by sector leaders. “Critically, the need for better training and education for all healthcare professionals comes up as a recurring theme of high priority as the industry continues to evolve,” says Tina Woods, Executive Director of the International Institute of Longevity.
Despite these limitations, 77% of clinics reported plans to expand operations – even as just 39% said they were currently profitable. While this may reflect long-term investor optimism in the field, it also points to a sector still in the early stages of maturity.
The survey also reveals how deeply digital health tools are integrated into longevity care. Over 70% of clinics support wearable data integration, and more than half have developed proprietary client tracking systems. Yet only 40% have fully integrated their longevity protocols with electronic medical records – a finding that highlights both technical hurdles and philosophical boundaries between conventional and longevity-focused care models.
Technology is also shaping diagnostics. A majority of clinics offer advanced biological age tests, and 51% view “pace of aging” as a reliable marker for tracking health trajectories – though views on testing intervals vary, with opinions split between 6-month and annual retesting. Clinics use a broad suite of diagnostics, with over 85% assessing metabolic, liver and renal function, but just 37% include oral health assessments, and only 22% offer hearing tests – two domains with known impact on healthy aging.
Professor Andrea Maier, who contributed expert commentary to the report, notes: “Cognitive assessments, which is vital for determining patient needs, are implemented in fewer than 60% of clinics, suggesting a gap in comprehensive longevity evaluations.” She further highlights concerns around clinical rigor: “Many clinics offer peptide and stem cell therapies without clear longevity-related indications… nearly two-thirds of clinics either administer or plan to administer IV therapies such as NAD+ infusions, despite a lack of supporting evidence.”
There is wide support, however, for greater cohesion in the field. Nearly three-quarters of clinics are willing to share anonymized data to support better outcomes, and 64% say they would adapt their protocols to align with international standards. As Joanna Bensz, CEO of Longevity Center Europe, observes: “Coinciding with the advances in AI we are seeing, it is not a surprise that clinics are starting to recognize the importance of sharing anonymized data, agreeing on most useful biomarkers and biological age assessments, while aligning with international standards too.”
The age of clients also reflects the strategic positioning of most clinics. Over 75% of patients fall within the Gen X cohort (aged 44–59), with fewer Boomer and Millennial clients represented. Respondents cited marketing, cost and perceived relevance as contributing factors – an insight likely to inform how clinics evolve their offerings and communications in future.
Clinics themselves see the need for increased professionalism and transparency. One practitioner wrote: “We need to be more specific with our protocols. Set for transparency… regroup professional longevity clinics within a quality standard to create a better visibility to patients and customers.”
For Dr David Luu, founder of Longevity Docs, the direction is clear: “We now have an extraordinary opportunity to build the foundations of longevity medicine. By uniting physicians through structured education and decentralized research, we can accelerate innovation, validate interventions, and bring the promise of healthy longevity to billions.”
As the field continues to grow – commercially, medically and culturally – the need for credible, patient-centered, evidence-informed practice becomes ever more pressing. As Ruiz puts it: “Longevity medicine should be an inclusive health revolution, rather than an exclusive pursuit of the ultra-wealthy as it historically has been.”
Read the full Longevity Clinics Survey 2025 report HERE.